Cannabis / CBD for Tinnitus: What Does the Evidence Show?

Complementary & Alternative

Current evidence

'CBD for tinnitus' is aggressively marketed. There are zero human trials — and population data point the wrong way.

Evidence strength: Weak (1/5) · Tier 5 — weak or unsupported · Evidence independence: Independence unclear.

Cannabis and cannabidiol products marketed for tinnitus relief, riding the general CBD wellness wave (~20% of US adults used CBD in 2022).

Did tinnitus loudness improve?

None shown. No human trials at all.

Did tinnitus distress improve?

None shown. No human trials. NHANES population analysis: tinnitus prevalence is HIGHER among cannabis users (OR ~1.8 for high-volume use, adjusted).

Loudness means the tinnitus percept itself became quieter (psychoacoustic matching or loudness ratings). Distress means questionnaire scores such as THI/TFI, sleep, anxiety or quality of life improved — the sound may be unchanged. A THI/TFI improvement is never evidence the tinnitus got quieter.

How strong is the evidence?

No human evidence and a signal in the wrong direction: 1/5, Tier 5.

Has the result been independently replicated?

None yet.

What are the limitations?

Conflicts of interest: Marketing entirely industry-driven.

What should patients know about safety?

Safety evidence: Limited. Drug interactions, dependence potential (THC), unregulated product quality — plus the epidemiological association with more tinnitus, not less.

Is it available?

Regulatory status: Unregulated supplements / state-legal cannabis. No product has any tinnitus authorization anywhere.

Availability: Everywhere CBD is sold · Europe: Same · Cost (approx.): $30–100/month, indefinitely

What the studies found

No individual study records yet.

Related treatments

Evidence last reviewed: 2026-09-03 · Evidence included through: 2026-09-03 · Confidence: high. Open the interactive evidence profile.

This page summarizes published research for education. It is not medical advice; it cannot say what will work for any individual. Discuss treatment decisions with a qualified clinician.